ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
205.17
-8.18 (-3.83%)
At close: Apr 4, 2025, 4:00 PM
193.58
-11.59 (-5.65%)
After-hours: Apr 4, 2025, 8:00 PM EDT

ResMed Market Cap

ResMed has a market cap or net worth of $30.07 billion as of April 4, 2025. Its market cap has increased by 6.28% in one year.

Market Cap
30.07B
Enterprise Value
30.39B
1-Year Change
6.28%
Ranking
Category
Stock Price
$205.17

Market Cap Chart

Since December 1, 1998, ResMed's market cap has increased from $485.80M to $30.07B, an increase of 6,090.56%. That is a compound annual growth rate of 16.94%.

History

DateMarket Cap% Change
Apr 4, 202530.13B-10.24%
Dec 31, 202433.57B32.68%
Dec 29, 202325.30B-17.01%
Dec 30, 202230.49B-19.68%
Dec 31, 202137.96B23.23%
Dec 31, 202030.80B38.24%
Dec 31, 201922.28B37.32%
Dec 31, 201816.23B35.02%
Dec 29, 201712.02B37.39%
Dec 30, 20168.75B16.66%
Dec 31, 20157.50B-4.09%
Dec 31, 20147.82B16.86%
Dec 31, 20136.69B12.47%
Dec 31, 20125.95B40.80%
Dec 30, 20114.22B-19.35%
Dec 31, 20105.24B33.67%
Dec 31, 20093.92B38.11%
Dec 31, 20082.84B-30.14%
Dec 31, 20074.06B8.50%
Dec 29, 20063.74B38.30%
Dec 30, 20052.71B56.41%
Dec 31, 20041.73B22.93%
Dec 31, 20031.41B39.73%
Dec 31, 20021.01B-41.47%
Dec 31, 20011.72B39.28%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 662.90B
UnitedHealth Group 480.27B
Johnson & Johnson 369.29B
AbbVie 330.73B
Novo Nordisk 283.87B
AstraZeneca 216.62B
Abbott Laboratories 215.82B
Merck & Co. 205.80B
Market Cap Rankings